top of page
grey-9026_256.gif

$1.1 Million EBITDA, Electrotherapy TENS Device Company in Texas

Listing Code:

TXDME1W

UNDER LOI

State:

Texas

Category:

DME & HME

Asking Price:

$9,000,000

Revenue:

$2,900,000

TXDME1W
Company Overview

PRIME exits® and American HealthCare Capital are pleased to exclusively introduce a well-established medical device company specializing in non-invasive electro-therapy solutions designed to alleviate pain and improve patient outcomes. The company has built a strong reputation over more than two decades by providing high-quality Transcutaneous Electrical Nerve Stimulation (TENS) devices and related therapeutic products to healthcare providers and their patients.

Core Competencies
  • Strong physician and therapist referral network driving consistent revenue

  • Robust compliance program

  • Customized, easy-to-use electro-therapy devices that support at-home patient care

  • Decades of industry experience with a loyal customer base

  • Scalable business model with recurring revenue streams

Differentiators
  • High revenue growth of 84% CAGR over 3 years

  • Strong Adjusted EBITDA Margins of 38% and Gross Profit Margin of 77%

  • Patient growth rates of 87% CAGR from 218 to 1,443 over 3 years

  • Robust compliance program

  • Physician and Therapist-driven referrals, ensuring strong medical credibility and patient retention

Product and Payer Mix

The Company’s product mix is 90% Electrodes, 5% TENS Devices, and 5% Braces. The Company’s payer mix consists of 100% Commercial Insurance.

Staff Overview

The Company’s team is expected to remain in place under new ownership, including 8 employees and 7 independent contractors.

Financial Overview

The Company’s revenue has increased significantly from 2022 to 2025 at a compounded annual growth rate (CAGR) of 84% while achieving a 34% adjusted EBITDA margin. The Company expects to continue its double-digit growth rates from a strong first quarter of new patients in 2026.  Total 2026 revenues are forecasted to grow to $2.9 million and $1.1 million in Adjusted EBITDA (38%).

Asking Price

The asking price is $9 Million plus an earn-out going forward. The Seller will consider a majority sale and rollover of equity while remaining involved post-close. This does not include cash, receivables, or working capital

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

TXDME1W

Listing Title:

$1.1 Million EBITDA, Electrotherapy TENS Device Company in Texas

Heading 4

Need to learn more before Signing an NDA- Contact the Lead Advisor For This Mandate

Listing Title:

Error
Error

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings

About PRIME exits®
​

​​

​

Locations
Copyrights Reserved 2026 @ PRIME exits®
bottom of page